Stock A086450 DONGKOOK PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company DongKook Pharmaceutical Co., Ltd.

Equities

A086450

KR7086450004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
17,700 KRW +2.25% Intraday chart for DongKook Pharmaceutical Co., Ltd. +4.12% +9.53%
14/03 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

DongKook Pharmaceutical Co., Ltd. is a Korea-based company engaged in the development, manufacture and distribution of pharmaceuticals. The Company develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. It also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The Company distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Number of employees: 1,105

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
101.2 %
675,316 102.1 % 740,091 101.2 % +9.59%
Elimination
-1.2 %
-13,668 -2.1 % -9,097 -1.2 % -33.44%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
90.2 %
593,757 89.7 % 659,134 90.2 % +11.01%
Overseas
9.8 %
67,891 10.3 % 71,860 9.8 % +5.85%

Managers

Managers TitleAgeSince
Joon-Ho Song CEO
 Chief Executive Officer 56 01/12/01
Gi-Beum Kwon CHM
 Chairman 57 01/94/01
Yoon-Hwan Son AUD
 Comptroller/Controller/Auditor 65 -
Jae-Seong Koo PRN
 Corporate Officer/Principal 62 -
Hee-Soon Park PRN
 Corporate Officer/Principal 59 -
Seh-Il Jeon PRN
 Corporate Officer/Principal 65 -

Members of the board

Members of the board TitleAgeSince
Gi-Beum Kwon CHM
 Chairman 57 01/94/01
Joon-Ho Song CEO
 Chief Executive Officer 56 01/12/01
Chae-Gun Im BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,460,000 23,933,979 ( 53.83 %) 497,680 ( 1.119 %) 53.83 %
Stock B 0 770,420 0 0

Shareholders

NameEquities%Valuation
Gi-Beum Kwon
40.48 %
17,998,830 40.48 % 215 M ₩
VIP Research & Management Inc.
6.314 %
2,807,258 6.314 % 33 M ₩
Jae-beom Kwon
3.673 %
1,633,200 3.673 % 19 M ₩
DONGKOOK PHARMACEUTICAL CO., LTD.
1.070 %
475,900 1.070 % 6 M ₩
Su-yeon Kwon
0.6034 %
268,280 0.6034 % 3 M ₩
Yoon-jeong Kwon
0.5113 %
227,326 0.5113 % 3 M ₩
Soon-ja Yoon
0.2895 %
128,710 0.2895 % 2 M ₩
Byung-Hoon Kwon
0.1828 %
81,270 0.1828 % 969 054 ₩
Dongkook Pharmaceutical Co., Ltd. ESOA
0.0625 %
27,785 0.0625 % 331 305 ₩
Haitong International Asset Management (HK) Ltd.
0.0585 %
26,000 0.0585 % 310 021 ₩
NameEquities%Valuation
Gi-Beum Kwon
45.00 %
346,685 45.00 % 4 M ₩

Holdings

NameEquities%Valuation
DONGKOOK PHARMACEUTICAL CO., LTD.
1.07%
 475,900 1.07% 5,674,574 $
S.BIOMEDICS CO., LTD.
0.97%
 111,112 0.97% 2,741,422 $
TS NEXGEN CO., LTD.
1.30%
 1,495,393 1.30% 949,978 $
LINKED INC.
0.39%
 250,000 0.39% 128,248 $

Company contact information

DongKook Pharmaceutical Co., Ltd.

715 Yeongdong-daero Gangnam-gu

06072, Seoul

+

http://www.dkpharm.co.kr
address DongKook Pharmaceutical Co., Ltd.(A086450)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for DongKook Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17,700 KRW
Average target price
24,000 KRW
Spread / Average Target
+35.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
DONGKOOK PHARMACEUTICAL CO., LTD. Stock DongKook Pharmaceutical Co., Ltd.
+9.53% 575M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A086450 Stock
  4. Company DongKook Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW